MicroPort CardioFlow Medtech Corporation (HKG:2160)

Market Cap	4.02B +89.5%
Revenue (ttm)	402.73M -4.0%
Net Income	5.32M
EPS	0.01
Shares Out	1.27B
PE Ratio	276.91
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	12,817,066
Average Volume	1,306,058
Open	0.8500
Previous Close	0.8400
Day's Range	0.8100 - 0.8800
52-Week Range	0.8100 - 8.4500
Beta	0.30
RSI	23.11
Earnings Date	Mar 27, 2026

About HKG:2160

MicroPort CardioFlow Medtech Corporation, a medical device company, engages in the research, development, and commercialization of transcatheter and surgical solutions for structural heart diseases in the People’s Republic of China and internationally. The company engages in research and development, manufacture, and sale of medical devices in the field of left atrial appendage, and treating valvular heart diseases, as well as properties management. It’s product portfolio includes transcatheter aortic valves, left atrial appendage closure, tran...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2009
• Employees: 417
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 2160

Financial Performance

In 2024, HKG:2160's revenue was 361.57 million, an increase of 7.54% compared to the previous year's 336.22 million. Losses were -49.45 million, -89.51% less than in 2023.

Financial numbers in CNY